About Neumora
Neumora is a company based in Watertown (United States) founded in 2020 by Robert Nelsen, Kristina Burow, Carol Suh, Paul Berns, and Mike Poole.. Neumora has raised $612 million across 2 funding rounds from investors including Amgen, ARE and Citadel. The company has 110 employees as of December 31, 2024. Neumora offers products and services including Precision Toolbox and Drug Pipeline Programs. Neumora operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Watertown, United States
- Employees 110 as on 31 Dec, 2024
- Founders Robert Nelsen, Kristina Burow, Carol Suh, Paul Berns, Mike Poole
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neumora Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-243.79 M-3.33as on Dec 31, 2024
-
EBITDA
$-262.83 M-40.16as on Dec 31, 2024
-
Total Equity Funding
$612 M (USD)
in 2 rounds
-
Latest Funding Round
$112 M (USD), Series B
Oct 11, 2022
-
Investors
Amgen
& 16 more
-
Employee Count
110
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Neumora
Neumora is a publicly listed company on the NASDAQ with ticker symbol NMRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Neumora
Neumora offers a comprehensive portfolio of products and services, including Precision Toolbox and Drug Pipeline Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates tools for precision medicine in CNS diseases.
Pursues novel mechanisms for brain disease treatments.
Unlock access to complete
Unlock access to complete
Leadership Team
15 people
Scientific Team
11 people
Software Development Team
9 people
Senior Team
4 people
Human Resources and Administration
4 people
Product Management Team
4 people
Operations Team
3 people
Legal and Compliance
2 people
Unlock access to complete
Funding Insights of Neumora
Neumora has successfully raised a total of $612M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $112 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $112.0M
-
First Round
First Round
(07 Oct 2021)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series B - Neumora | Valuation | Amgen , Arch Venture Partners |
|
| Oct, 2021 | Amount | Series A - Neumora | Valuation | Arch Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neumora
Neumora has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, ARE and Citadel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Early stage life sciences sectors focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neumora
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neumora
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neumora Comparisons
Competitors of Neumora
Neumora operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neumora
Frequently Asked Questions about Neumora
When was Neumora founded?
Neumora was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Neumora located?
Neumora is headquartered in Watertown, United States.
Who is the current CEO of Neumora?
Paul Berns is the current CEO of Neumora. They have also founded this company.
Is Neumora a funded company?
Neumora is a funded company, having raised a total of $612M across 2 funding rounds to date. The company's 1st funding round was a Series A of $500M, raised on Oct 07, 2021.
How many employees does Neumora have?
As of Dec 31, 2024, the latest employee count at Neumora is 110.
What does Neumora do?
Neumora was founded in 2020 and is headquartered in Watertown, United States. Precision medicines targeting neuropsychiatric and neurodegenerative disorders are developed through a data-driven neuroscience platform. Technologies such as Data Biopsy Signatures and Precision Phenotypes are utilized to enable targeted therapies for brain diseases. The pipeline encompasses NMRA-140 for depressive disorders, NMRA-511 for anxiety and sleep issues, and NMRA-094 for neurodegenerative conditions.
Who are the top competitors of Neumora?
Neumora's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Neumora offer?
Neumora offers Precision Toolbox and Drug Pipeline Programs.
Is Neumora publicly traded?
Yes, Neumora is publicly traded on NASDAQ under the ticker symbol NMRA.
Who are Neumora's investors?
Neumora has 17 investors. Key investors include Amgen, ARE, Citadel, Mubadala, and Arch Venture Partners.
What is Neumora's ticker symbol?
The ticker symbol of Neumora is NMRA on NASDAQ.